Real Life Pharmacology - Pharmacology Education for Health Care Professionals

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

On this episode of the Real Life Pharmacology Podcast, I cover ziprasidone pharmacology.

Ziprasidone has dopamine blocking activity and is classified as a second generation antipsychotic.

Ziprasidone tends to have lower metabolic syndrome risks compared to other antipsychotics like clozapine and olanzapine.

QTc prolongation is a significant risk with ziprasidone and be aware of drug interactions and electrolyte imbalances that may increase this risk.

More episodes from Real Life Pharmacology - Pharmacology Education for Health Care Professionals